Obstructive sleep apnea syndrome (OSAS) is characterized by repetitive episodes of complete or partial upper airway obstruction during sleep. Repetitive episodes of airway obstruction lead to increasing respiratory efforts, intermittent arterial oxygen desaturation, systemic and pulmonary arterial blood pressure surges, and sleep disorders (1). We sleep occupies for nearly one-third of our life, and it is an essential and vital part of our life. Although it is perceived as a resting period for the body, during some stages of sleep, the brain and many bodily systems are extremely active. Sleep is evaluated in two stages as rapid eye movement (REM) and non-REM. The REM stage is named after REM during this phase. This stage is classified as tonic and phasic REM. During this stage, brain activity with mixed frequency, erection, thermoregulation loss, muscle twitching, cardiorespiratory disorder, respiratory control impairment, and irregular ventilation occur (2, 3). During REM, pharyngeal muscle activity decreases, and upper airway collapsibility increases as a result of the absence of excitatory, noradrenergic, and serotonergic stimuli in upper airway motor neurons (4). Therefore, in patients with OSAS during REM sleep, the number and duration of obstructive respiratory events increase with resultant serious oxygen desaturation. REM as a specific respiratory disorder was first described in 1996. From that day on, different expressions and diagnostic criteria have been used for the presence and definition of REM-related OSAS. Some authors have accepted this disorder as not a separate entity, but rather a component of an OSAS spectrum, and they indicated REM-related OSAS as an essentially early (baseline presentation) phase of classical OSAS, while others defined it as a different clinical type of OSAS (3, 5, 6) . In the present study, we aimed to compare the clinical and polysomnographic findings of REM-related and non-REM-related OSAS patients to test whether REM-related OSAS is a different clinical type OSAS or the manifestation of early stage or the onset of OSAS. 
METHODS

Subjects and Study Design
The medical records of patients over the age of 18 years who underwent polysomnography (PSG) between January 2011 and January 2014 with an initial diagnosis of sleep-related breathing disorder were retrospectively reviewed. Among them, those with an apnea-hypopnea index (AHI) of ≥5 and a diagnosis of OSAS were included in the study. Data related to demographic characteristics, sleep patterns, medical history, medication use, and habits were retrieved using a standardized questionnaire survey applied before the study. For the evaluation of sleepiness during the day, Epworth Sleepiness Scale (ESS) was used (7) . Based on their AHI, the patients were categorized in the mild (AHI=5-15), moderate (AHI=15-30), and severe OSAS (AHI>30) groups according to the American Academy of Sleep Medicine (AASM) Task Force criteria (8) . Respiratory events observed during each stage of sleep were determined, and AHI for REM (AHI REM ) and non-REM (AHI NREM ) were calculated. Similarly, AHI while the patient was sleeping in the supine (AHI SUPINE ) and other positions (AHI NON-SUPINE ) were also calculated. The study population was divided into two groups: those with AHI NREM of <5 and AHI REM /AHI NREM of >2 and those with OSAS whose REM sleep data were recorded for at least 30 min were classified as having "REM-related OSAS, " and those who did meet the criteria of this definition were classified as having "non-REM-related OSAS. " Patients with central sleep apnea syndrome, upper airway resistant syndrome, narcolepsy, and movement disorders were excluded from the study. We also excluded patients using drugs effective for REM sleep, including benzodiazepine derivatives and narcotics. This study was conducted in accordance with the tenets of the Declaration of Helsinki, and written informed consent was obtained from all subjects. The study protocol was reviewed and approved by the local institutional review board and ethics committee of Gaziosmanpaşa University.
Polysomnographic Evaluation
Overnight PSG was performed in all patients using a 55-channel polysomnograph (Alice® Sleepware, Philips Respironics, PA, USA) and included the following variables: electrooculograms (two channels), electroencephalograms (four channels), electromyograms of the submental muscles (one channel) and anterior tibialis muscle of both legs (two channels), electrocardiograms, airflow measurements (with oronasal thermistor and nasal cannula pressure transducer), body position sensor discerning changes in body position during sleep, and a snore sensor for the detection of snoring vibrations. Respiratory efforts of chest and abdominal muscles (two channels) were recorded using piezoelectric belts and arterial oxyhemoglobin saturation (SaO 2 : one channel) by pulse oximetry with a finger probe. The recordings were scored according to the standard criteria of AASM. Apnea was defined as ≥90% decrease in the air flow amplitude persisting for at least 10 s relative to the baseline amplitude. Hypopnea was defined as ≥50% decrease in air flow amplitude relative to the baseline values associated with a ≥3% oxygen desaturation or arousal from sleep, all sustaining for at least 10 s (9). AHI was calculated as the number of apneic plus hypopneic episodes per hour of sleep. Patients with AHI of ≥5 events/h were diagnosed as having OSAS. Oxygen desaturation index was defined as the total number of measurements of oxyhemoglobin desaturation of ≥4% within ≥10 s-<3 min from the baseline divided by the total sleep time.
Statistical Analysis
For the evaluation of categorical variables, chi-square test was used. Categorical variables were expressed as numbers and percentages. For categorical variables, histograms were employed. To test the normality of distribution of variables, Shapiro-Wilks normality test was utilized. For intergroup comparisons of continuous variables, independent samples t test or Mann-Whitney U test was used. In cases where parametric methods were used, continuous measurements were expressed as mean ± standard deviation, if nonparametric methods were used, variables were indicated as median and 25 and 75 percentiles. A multivariate logistic regression model was implemented to determine the relationship among selected variables and REM dependence. Variables whose significance is under 0.10 were added to the logistic regression model. p<0.05 was considered as the level of statistical significance. Calculations were performed using a pre-prepared statistical software program (IBM SPSS Statistics 19, SPSS Inc., IBM Co., Somers, New York, USA).
RESULTS
A total of 329 patients with a mean age of 51±10 years were evaluated. The patients were included in the REM-related (n=35; 10.6%) and non-REM-related (n=294; 89.4%) groups. The groups did not differ with regard to comorbidities, such as cerebrovascular disease, diabetes, hypertension, cardiovascular disease (this group included arrhytmia, congestive heart failure, and coronary artery disease); mean age; body mass index (BMI); ESS; and smoking history (p>0.05). The distribution of gender differed between groups (REM-related OSAS, male 51% and female 49%; non-REM-related, male 71% and female 26%, p=0.007) ( Table 1) . During PSG evaluation, AHI was lower, REM and NREM stage 3 sleep duration were longer, NREM stage 1 and 2 duration were shorter, and mean and minimum oxygen saturation values were higher in patients with REM-related OSAS with significant differences between groups (p<0.05) ( Table 2) . Also, 46% of REM-related OSAS patients had a position dependence (in the other group, this rate was only 19.7%) with a significant intergroup difference (p=0.001). In REM-related patients, mild (91.4%) and moderate (8.6%) degrees of OSAS were detected. This group did not contain
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Age ( Figure 1 ). Demographic findings and polysomnographic features of both groups are presented in Table  3 and Table 4 .
Potential determinants for REM dependence were further investigated in a univariate screening procedure. Subsequently, all parameters related to REM dependence with a significance level below 0.1 were introduced in a stepwise multiple regression analysis. The final regression model included age, gender, BMI, position dependence, AHI, desaturation %, average O 2 saturation, minimum O 2 saturation. The independent predictors of REM dependence were AHI and minimum O 2 saturation in patients with OSAS. Positional OSAS was not a significant factor for REM dependence (Table 5) .
DISCUSSION
The most striking outcome of our study is that severe OSAS patients were not encountered in the REM-related OSAS group, whereas the frequency of comorbidities such as cerebrovascular disease, diabetes, hypertension, and cardiovascular disease were similar to those in the non-REM-related group. Another important result of this study was that the mean age and BMI of both groups were comparable.
REM as a specific respiratory disorder was first described by Kass et al. (10) in 1996 as a cause of excessive daytime sleepiness. In a study where 34 patients with clinically suspect OSAS with respiratory disturbance index (RDI) of <10 were evaluated, in a substantial percentage of patients who described excessive daytime sleepiness, the presence of REM-related OSAS was demonstrated. From that day on, different expressions and diagnostic criteria have been used for the presence and definition of REM-related OSAS. Some authors accepted this disorder as not being a separate entity, but rather a component of an OSAS spectrum, and they indicated REM-related OSAS as an essentially early (baseline presentation) phase of classical OSAS (3, 5, 6). According to these authors, with aging and gaining weight (in the advanced stage of the disease in particular) of the patients, respiratory events seen only during the REM stage at the onset of Table 2 . Polysomnographic findings of the study population Table 3 . Demographic findings of both groups REM-related OSAS will be also observed during the non-REM stage. Thus, patients will enter into the advanced (severe) stage of OSAS, and respiratory pathologies will be seen both during the REM and non-REM stages of the disease.
The prevalence of REM-related OSAS varies within a wide spectrum (10-36%) (6, (11) (12) (13) . These highly variable outcomes stem from differences in criteria used for the definition of REM-related OSAS. It has been emphasized that AHI REM should be at least 2 times higher than AHI NREM ; however different values have been reported for AHI N-REM (AHI NREM <5 or <10) (11, 14, 15) . In studies that used diagnostic criteria similar to ours, AHI have ranged between 10% and 13% (16, 17 Because of differences in the definition criteria, in cases with REM-related OSAS, clinical characteristics also demonstrate differences. In many studies, a higher incidence of REM-related OSAS has been reported in women (3, 6, 12, 13, 19, 20) . Higher AHI REM relative to AHI NREM in women suggest the protection of women from respiratory events in NREM sleep. This protection has a physiological basis. During wakefulness, the activity of the genioglossus muscle is more potent when compared with men (21) . During NREM sleep, the resistance of the upper respiratory tract and collapsibility is lower in women (22) . The respiratory center-stimulating effect of progesterone together with its protective effect against upper respiratory tract obstruction by increasing the tonus of the pharyngeal dilator muscle account for the protection of women against respiratory events during NREM sleep (23) . On the other hand, during REM, a decrease in ventilatory response, pharyngeal muscle tone, and as a probability, reduced protective effect of sex hormones tend to increase the constriction of the upper respiratory tract (18) . The abovementioned mechanisms may explain the reason for the higher incidence of REM-related OSAS in women; however, some outcomes suggest comparable incidence rates between men and women (24, 25) . In our study, in REM-related and non-related groups, female patients constituted 49% and 26% of the patient population, respectively. Even though an increased number of female patients was detected in the REM-related OSAS group than in the other group, in the REM-related OSAS group, male predominance (51%) prevailed. Another point that demonstrated intergroup difference is that REM-related OSAS patients are relatively younger. The authors attributed the younger patient population in the REM-related OSAS group to its being the early phase presentation of classical OSAS. On the other hand, in various studies, authors could not detect any difference between the mean ages of patients with or without REM-related OSAS (3, 11, 24) . Also, in our study, the mean ages of patients in both groups were found to be similar. Table 5 . Logistic regression analysis for REM-dependent OSAS Obesity is an important risk factor in the development of OSAS (26) . In the development of REM-related OSAS, the role of obesity is not clear. In a study population of 419 patients, logistic regression analysis was performed to predict REM-related OSAS. In total, 138 patients with REM-related OSAS were detected, and higher BMI was concluded to be an independent variable. The use of only AHI REM >2 × AHI NREM criterion to define REM-related OSAS, and the detection of increased incidence (32.9%) of REM-related patients in that study have been criticized (3). Lakadamyalı et al. (24) found similar BMIs between REM-related and non-related groups, and in the former group, a higher number of female participants were obese compared with male participants. In our study, the mean BMI values did not differ between groups regarding the gender of the patients.
REM-Related and Non-REM-Related OSAS (n=329)
REM-related OSAS was first described in 1996 as a cause of excessive daytime sleepiness, and with subsequent studies on REM-related OSAS, higher ESSs were more frequently detected in patients with REM-related OSAS. However, some authors obtained similar incidence rates of sleepiness in patients with non-REM-related OSAS (3, 24, 25) . Additionally, in our study, the mean ESSs were similar between both groups.
Patients with REM-related OSAS are generally in mild-moderate OSAS groups, and this group rarely contains severe patients (3, 6, 11-13, 20, 24, 25, 27) . Also, in our study, the REM-related OSAS group consisted of only patients with mild and moderate degrees of OSAS without any patient with severe OSAS. Another striking feature of our study is that 46% of patients with REM-related OSAS also had positional OSAS (20% in the other group) with a significant intergroup difference. However, positional OSAS was not a significant factor for REM dependence in multiple regression analyses. AHI and minimum O 2 saturation were independent predictors. For the definition of positional OSAS, the combined criteria of AHI NON-SUPINE of <5 and AHI SUPINE of ≥2 × AHI NON-SUPINE were used (28) . While sleeping in the supine position, the tongue and soft palate posteriorly deviate, which decrease pharyngeal cross-sectional area, leading to an increase in the frequency of respiratory events (29) . As a combined effect of REM sleep and the supine position, preexisting OSAS will be fuırther aggravated, and oxygen saturation will decrease. Therefore, when evaluating the PSG reports of patients with OSAS, AHI recorded at every stage of sleep and at all sleeping positions should be carefuly assessed.
Sleep architecture in patients with REM-related OSAS and non-REM-related groups demonstrates intergroup differences. Lakadamyalı et al. (24) observed comparable duration and percentage of hours slept in both the REM-related and non-related groups, while shorter NREM stage 1 and 2 sleep, but longer stage 3 sleep, were observed. In a separate study performed in an REM-related group, longer REM and deep sleep, but decreased NREM stage 1 sleep, were detected (3). In the REM-related group, we observed longer REM and NREM stage 3 sleep, but shorter stage1 and 2 sleep.
REM sleep is characterized by a period of increased sympathetic activity and cardiovascular instability both in normal individuals and in those with OSAS. When episodes of obstructive apnea-hypopnea occurring during the REM stage are compared to respiratory events occurring during the NREM stage, the former episodes induce deeper hypoxemia and increased sympathetic activity. Therefore, REM-related respiratory events are associated with marked increases in cardiovascular risk (18) . A striking finding is that in non-obese children with OSAS, REM-related OSAS is more frequently detected (19) . In studies performed on children with OSAS, the development of morbidities as metabolic dysfunction, hypertension, vascular endothelial dysfunction, systemic inflammation, and increased oxidative stress have been demonstrated (30) (31) (32) (33) . Observations gathered from children display their importance in the definition of REM-related events in adults. The most striking outcome of our study is that comorbidities such as cerebrovascular disease, diabetes, hypertension, cardiovascular diseases, which are mostly seen in severe OSAS patients, were observed in a nearly equal number of patients in the REM-related group with mild-moderate OSAS and the non-REM-related group, which contained severe patients with OSAS. These results suggest that that REM-related OSAS is a different and important clinical entity. In a study by Rodríguez et al. (3) , no difference was detected between REM-related and non-REM-related OSAS groups in cardiovascular risk factors and cardiovascular events. These outcomes demonstrate the importance of an early diagnosis and the treatment of patients with REM-related OSAS for the prevention of many significant systemic complications.
CONCLUSION
In light of the data obtained from our study, similarities between the REM-related OSAS and non-REM-related groups in mean age, BMI, and ESS and the lack of any intergroup difference between groups regarding the incidence rates of concomitant diseases such as as cardiovascular disease, diabetes, hypertension, and cardiovascular disease suggest that REM-related OSAS is a different clinical type of OSAS rather than a presentation of the beginning or early stages of classical OSAS. OSAS is a heterogenous syndrome including patients with different clinical features. Therefore, the determination of clinical types of OSAS and the early onset of appropriate therapy increase a patient's compliance to treatment and thus, treatment success rates. Besides, it has an importance in the prevention of many OSAS-related systemic complications.
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